HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 162 filers reported holding HAEMONETICS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,213,926 | -66.8% | 14,258 | -67.7% | 0.03% | -68.0% |
Q1 2023 | $3,658,129 | -28.6% | 44,207 | -32.1% | 0.10% | -31.0% |
Q4 2022 | $5,120,194 | +380.3% | 65,101 | +352.2% | 0.14% | +291.9% |
Q3 2022 | $1,066,000 | -87.1% | 14,396 | -88.6% | 0.04% | -90.0% |
Q2 2022 | $8,241,000 | +3715.3% | 126,439 | +3604.6% | 0.37% | +3590.0% |
Q1 2022 | $216,000 | -48.2% | 3,413 | -56.6% | 0.01% | -61.5% |
Q4 2021 | $417,000 | +19.8% | 7,869 | +168.8% | 0.03% | -29.7% |
Q4 2020 | $348,000 | -17.9% | 2,928 | -39.7% | 0.04% | +37.0% |
Q3 2020 | $424,000 | -42.5% | 4,857 | -24.3% | 0.03% | -38.6% |
Q4 2019 | $737,000 | -22.3% | 6,417 | -14.7% | 0.04% | -46.3% |
Q3 2019 | $949,000 | -10.3% | 7,526 | -37.8% | 0.08% | +9.3% |
Q1 2019 | $1,058,000 | +344.5% | 12,093 | +481.4% | 0.08% | +316.7% |
Q3 2018 | $238,000 | -92.7% | 2,080 | -94.3% | 0.02% | -92.0% |
Q2 2018 | $3,261,000 | +139.6% | 36,365 | +95.4% | 0.23% | +137.9% |
Q1 2018 | $1,361,000 | +194.6% | 18,609 | +80.6% | 0.10% | -18.1% |
Q3 2017 | $462,000 | +71.7% | 10,302 | +54.2% | 0.12% | +169.8% |
Q4 2016 | $269,000 | -25.5% | 6,682 | -46.3% | 0.04% | -8.5% |
Q2 2016 | $361,000 | -7.7% | 12,445 | +2.9% | 0.05% | +38.2% |
Q3 2015 | $391,000 | – | 12,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |